Hybrid Clinical Trial Site Activation Expert

Immix Biopharma (Nasdaq: IMMX); Toronto; Hybrid; CAD 90,000 - 130,000; Full time

Job summary

Immix Biopharma, Inc. is seeking a Clinical Trial Site Activation Specialist to drive end-to-end site activation during study start-up in a hybrid Toronto setting. You will coordinate regulatory submissions, budget discussions, and essential document collection to ensure timely study launches.

You'll partner with CRAs, sites, and cross-functional teams, applying GCP/ICH knowledge to maintain TMF/CTMS quality and compliance, while tracking milestones and contributing to project success.

Qualifications

• Bachelor’s degree in life sciences or healthcare field.
• 2–5+ years in clinical research focusing on study start-up or site activation.
• Strong knowledge of GCP/ICH guidelines and local regulatory requirements.

Responsibilities

• Coordinate end-to-end site start-up and activation per project timelines.
• Prepare and track regulatory and IRB/EC submissions.
• Support CTA and budget negotiations between sponsors and sites.
• Manage TMF/CTMS document collection and quality checks.
• Maintain proactive communication with sites, CRAs and project leads.
• Monitor startup metrics and update forecasting dashboards.

Skills

Communication

Organizational skills

Cross-functional collaboration

Education

Bachelor’s degree in life sciences or related field

Tools

CTMS

eTMF

Regulatory platforms

Job description

Immix Biopharma, Inc. is seeking a Clinical Trial Site Activation Specialist to drive end-to-end site activation during study start-up in a hybrid Toronto setting. You will coordinate regulatory submissions, budget discussions, and essential document collection to ensure timely study launches.

You'll partner with CRAs, sites, and cross-functional teams, applying GCP/ICH knowledge to maintain TMF/CTMS quality and compliance, while tracking milestones and contributing to project success.